21.2 C
New York
Thursday, June 18, 2026

Tag: analytics

Verisk Analytics, Inc. Prices Offering of Senior Notes

JERSEY CITY, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verisk Analytics, Inc. (Nasdaq: VRSK) (“Verisk” or the “Company”), a leading global data analytics and technology provider, today announced the pricing of an offering of $750 million of 4.500% Senior Notes due 2030 (the “2030 Notes”) and $750 million of 5.125% Senior Notes due 2036 (the “2036 Notes” and, together with the 2030 Notes, the “Notes”). The closing of the offering is expected to occur on August 21, 2025, subject to satisfaction of customary closing conditions.

Quantiphi Achieves Google Cloud Data Management Specialization

MARLBOROUGH, Mass., Aug. 7, 2025 /PRNewswire/ -- Quantiphi, an AI-first digital engineering company, today announced it has achieved the Google Cloud Partner Advantage Specialization...

Oracle Helps Customers Achieve Extreme Availability and Performance for Mission-Critical and Agentic AI Applications

With Oracle Globally Distributed Exadata Database on Exascale Infrastructure, customers can run distributed workloads of all types, including agentic AI, analytics, and transactional while...

Brightstar Lottery Upgrades Retail Central System for Lotto Saxony in Germany via New Seven-Year Contract

LONDON, Aug. 7, 2025 /PRNewswire/ -- Brightstar Lottery PLC (NYSE: BRSL) ("Brightstar") announced today that it will deploy its comprehensive retail central system technology,...

oneZero appoints Adam Collins as Head of Institutional Sales, Americas and EMEA

SOMERVILLE, Mass., Aug. 7, 2025 /PRNewswire/ -- oneZero, a global leader in multi-asset enterprise trading technology, today announced the appointment of Adam Collins as...

Pason Reports Second Quarter 2025 Results and Declares Quarterly Dividend

CALGARY, AB, Aug. 6, 2025 /CNW/ - Pason Systems Inc. ("Pason" or the "Company") (TSX: PSI) (OTC: PSYTF) announced today its 2025 second quarter...

Advanced In Vivo Efficacy Models for Preclinical Success, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how in vivo PK/PD and efficacy models drive progress in oncology, immunology and fibrosis, with real-world case studies showcasing...

TOC Logistics Goes Live with Made4net’s Synapse 3PLExpert WMS

Leading 3PL Selects Made4net to Streamline Complex Operations and Drive Scalable Growth Across Multi-Site Network TEANECK, N.J., Aug. 6, 2025 /PRNewswire/ -- Made4net, a leading provider...

Honda and the Honda USA Foundation Empower Millions of Individuals Across America through Annual Charitable Giving Campaign

Honda and the Honda USA Foundation contribute over $16.5 million during annual programmatic funding cycleThis year's funding supports 223 programs across five key corporate...

Synechron Expands Cybersecurity Offering with New AI-Powered Accelerators

PUNE, India and LONDON and NEW YORK, Aug. 6, 2025 /PRNewswire/ -- Synechron, a leading global digital transformation consulting firm, today announced the expansion of...

Dun & Bradstreet India Celebrates 30 Years of Empowering Business Growth

MUMBAI, India, Aug. 6, 2025 /PRNewswire/ -- Dun & Bradstreet India, a leading provider of business decisioning data and analytics, proudly celebrates its 30th anniversary—marking three...

VPN.com Lists MarketCap.com For Sale: Premium Asset For Financial and Crypto Leaders

ATLANTA, Aug. 5, 2025 /PRNewswire/ -- VPN.com officially announces that MarketCap.com, one of the most sought-after domain names in the financial and crypto industries,...

Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

WARREN, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its artificial intelligence initiative, Tevogen.AI, is expanding its collaboration with Microsoft (Nasdaq: MSFT) and Databricks, to build the beta version of its foundational PredicTcell model.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAnalytics